Matrix metalloproteinases as therapeutic targets in breast cancer

MJ Kwon - Frontiers in Oncology, 2023 - frontiersin.org
Matrix metalloproteinases (MMPs) are the most prominent proteinases involved in
tumorigenesis. They were initially recognized to promote tumor progression by remodeling …

[HTML][HTML] Matrix metalloproteinases as breast cancer drivers and therapeutic targets

ES Radisky, DC Radisky - Frontiers in bioscience (Landmark …, 2015 - ncbi.nlm.nih.gov
Members of the matrix metalloproteinase (MMP) family have been identified as poor
prognosis markers for breast cancer patients and as drivers of many facets of the tumor …

Breast cancer progression: insights into multifaceted matrix metalloproteinases

V Chabottaux, A Noel - Clinical & experimental metastasis, 2007 - Springer
The restricted view of matrix metalloproteinases (MMPs) as simple destroyers of
extracellular matrix components has largely ignored their substantial contribution in many …

Therapeutic potential of matrix metalloproteinase inhibition in breast cancer

ES Radisky… - Journal of cellular …, 2017 - Wiley Online Library
Matrix metalloproteinases (MMPs) are a family of zinc endopeptidases that cleave nearly all
components of the extracellular matrix as well as many other soluble and cell‐associated …

Matrix Metalloproteinases: A challenging paradigm of cancer management

A Alaseem, K Alhazzani, P Dondapati, S Alobid… - Seminars in cancer …, 2019 - Elsevier
Matrix metalloproteinases (MMPs) are members of zinc-dependent endopeptidases
implicated in a variety of physiological and pathological processes. Over the decades …

[HTML][HTML] Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database

PM McGowan, MJ Duffy - Annals of oncology, 2008 - Elsevier
Traditionally, matrix metalloproteinases (MMPs) have been implicated in cancer invasion
and metastasis. Because of their role in these processes, several MMPs have been …

Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects

MD Sternlicht, G Bergers - Emerging Therapeutic Targets, 2000 - Taylor & Francis
A major hallmark of malignant disease is the capacity of cancer cells to cross tissue
boundaries and spread to distant sites throughout the body. Extracellular matrix-degrading …

Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature

A Köhrmann, U Kammerer, M Kapp, J Dietl, J Anacker - BMC cancer, 2009 - Springer
Abstract Background Matrix metalloproteinases (MMPs) are a family of structural and
functional related endopeptidases. They play a crucial role in tumor invasion and building of …

Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology

LGN de Almeida, H Thode, Y Eslambolchi… - Pharmacological …, 2022 - ASPET
The first matrix metalloproteinase (MMP) was discovered in 1962 from the tail of a tadpole by
its ability to degrade collagen. As their name suggests, matrix metalloproteinases are …

Matrix metalloproteinases: multifunctional contributors to tumor progression

LJ McCawley, LM Matrisian - Molecular medicine today, 2000 - cell.com
Matrix metalloproteinases (MMPs) are a family of extracellular matrix degrading proteinases.
Owing to their matrix-degrading abilities and high expression in advanced tumors, MMPs …